DE69232002T2 - Immunoassays unter Verwendung von markierten Hapten-Analogen - Google Patents

Immunoassays unter Verwendung von markierten Hapten-Analogen

Info

Publication number
DE69232002T2
DE69232002T2 DE69232002T DE69232002T DE69232002T2 DE 69232002 T2 DE69232002 T2 DE 69232002T2 DE 69232002 T DE69232002 T DE 69232002T DE 69232002 T DE69232002 T DE 69232002T DE 69232002 T2 DE69232002 T2 DE 69232002T2
Authority
DE
Germany
Prior art keywords
label
analogue
immunoassay
groups
phenobarbital
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69232002T
Other languages
German (de)
English (en)
Other versions
DE69232002D1 (de
Inventor
Barbara A. Brummond
Susan Jean Danielson
David Alan Hilborn
Marsha D. Oenick
Ignazio Salvatore Ponticello
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ortho Clinical Diagnostics Inc
Original Assignee
Johnson and Johnson Clinical Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson and Johnson Clinical Diagnostics Inc filed Critical Johnson and Johnson Clinical Diagnostics Inc
Application granted granted Critical
Publication of DE69232002D1 publication Critical patent/DE69232002D1/de
Publication of DE69232002T2 publication Critical patent/DE69232002T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • G01N33/54386Analytical elements
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/948Sedatives, e.g. cannabinoids, barbiturates
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/815Test for named compound or class of compounds
    • Y10S436/816Alkaloids, amphetamines, and barbiturates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Anesthesiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69232002T 1991-06-07 1992-06-02 Immunoassays unter Verwendung von markierten Hapten-Analogen Expired - Lifetime DE69232002T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71232891A 1991-06-07 1991-06-07
US85143692A 1992-03-16 1992-03-16

Publications (2)

Publication Number Publication Date
DE69232002D1 DE69232002D1 (de) 2001-09-20
DE69232002T2 true DE69232002T2 (de) 2002-06-06

Family

ID=27108808

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69232002T Expired - Lifetime DE69232002T2 (de) 1991-06-07 1992-06-02 Immunoassays unter Verwendung von markierten Hapten-Analogen

Country Status (5)

Country Link
US (1) US5601994A (fr)
EP (1) EP0517327B1 (fr)
JP (1) JP3190730B2 (fr)
AT (1) ATE204385T1 (fr)
DE (1) DE69232002T2 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2960628B2 (ja) * 1992-06-26 1999-10-12 イーストマン コダック カンパニー 標識サイロニンハプテン類似体を用いたイムノアッセイ
ATE161962T1 (de) * 1992-08-07 1998-01-15 Johnson & Johnson Clin Diag Immunoassays unter verwendung von, mit meerrettich-peroxidase markierten carbamazepin- analogen
US5565326A (en) 1994-05-31 1996-10-15 Johnson & Johnson Clinical Diagnostics, Inc. Separation-free specific binding assays using anti-inhibitor antibodies
US5650324A (en) 1994-05-31 1997-07-22 Johnson & Johnson Clinical Diagnostics, Inc. Inhibitor and anti-inhibitor monoclonal antibodies specific for horseradish peroxidase
US5589344A (en) * 1994-06-15 1996-12-31 Johnson & Johnson Clinical Diagnostics, Inc. Test kit and method for competitive specific binding assay
AU697785B2 (en) 1994-07-19 1998-10-15 Johnson & Johnson Clinical Diagnostics, Inc. Analytical element,composition and method using modified apo-horseradish peroxidase
ES2167278B1 (es) * 2000-10-24 2003-08-16 Univ Murcia Enzima con actividad peroxidasa aislada de la alcachofa (cynara scolymus, l.) procedimiento para su aislamiento y purificacion y aplicaciones.
US8133743B2 (en) 2007-10-19 2012-03-13 Roche Diagnostics Operations, Inc. Phenobarbital derivatives useful in immunoassay
CN104736561B (zh) 2012-08-21 2018-06-12 詹森药业有限公司 帕潘立酮的抗体及其用途
AU2013305938B2 (en) 2012-08-21 2017-08-17 Saladax Biomedical Inc. Antibodies to paliperidone haptens and use thereof
CN104736565B (zh) 2012-08-21 2019-03-12 詹森药业有限公司 利培酮半抗原的抗体及其用途
JP6389177B2 (ja) 2012-08-21 2018-09-12 ヤンセン ファーマシューティカ エヌ.ベー. オランザピンハプテンに対する抗体及びその使用
CN107043424B (zh) 2012-08-21 2021-03-16 詹森药业有限公司 利培酮的抗体及其用途
JP6949025B2 (ja) 2015-12-17 2021-10-13 ヤンセン ファーマシューティカ エヌ.ベー. リスペリドンに対する抗体及びその使用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3875011A (en) * 1972-11-06 1975-04-01 Syva Co Enzyme immunoassays with glucose-6-phosphate dehydrogenase
US4065354A (en) * 1974-10-10 1977-12-27 Syva Company Lysozyme conjugates for enzyme immunoassays
US4213964A (en) * 1978-12-07 1980-07-22 Miles Laboratories, Inc. Diphenylhydantoin antibodies
IL59065A0 (en) * 1979-01-18 1980-05-30 Beecham Group Ltd Hydantoin derivatives,their preparation pharmaceutical compositons containing them
US4404366A (en) * 1980-05-06 1983-09-13 Miles Laboratories, Inc. Beta-galactosyl-umbelliferone-labeled hapten conjugates
NZ199629A (en) * 1981-02-17 1984-11-09 Abbott Lab Fluorescent polarisation immunoassay and certain substituted carboxy fluoresceins
US4378428A (en) * 1981-03-30 1983-03-29 Baker Instruments Corporation Method for carrying out non-isotopic immunoassays, labeled analytes and kits for use in such assays
US4447529A (en) * 1981-07-06 1984-05-08 Miles Laboratories, Inc. Preparing homogeneous specific binding assay element to avoid premature reaction
US4752568A (en) * 1986-01-13 1988-06-21 Eastman Kodak Company Labeled hydantoin conjugate and its use in analytical element and immunoassays
CA1300499C (fr) * 1987-08-03 1992-05-12 Susan J. Danielson Reactif insoluble dans l'eau, elements qui en contiennent et methode d'utilisation
DK0386644T3 (da) * 1989-03-10 1997-10-13 Hoffmann La Roche Reagenser til bestemmelse af lægemidler
US5096838A (en) * 1989-11-27 1992-03-17 Abbott Laboratories Barbiturate assay compositions and methods
US5162219A (en) * 1990-06-18 1992-11-10 Eastman Kodak Company Preparation of amine-enriched proteins having an increased isoelectric point

Also Published As

Publication number Publication date
EP0517327A3 (en) 1993-05-05
JPH0627108A (ja) 1994-02-04
ATE204385T1 (de) 2001-09-15
EP0517327B1 (fr) 2001-08-16
JP3190730B2 (ja) 2001-07-23
US5601994A (en) 1997-02-11
EP0517327A2 (fr) 1992-12-09
DE69232002D1 (de) 2001-09-20

Similar Documents

Publication Publication Date Title
DE69231382T2 (de) Neue konjugate und testverfahren für die gleichzeitige bestimmung von multiplen liganden
DE69232002T2 (de) Immunoassays unter Verwendung von markierten Hapten-Analogen
DE19621133A1 (de) Bestimmungsverfahren mit oligomerisierten Rezeptoren
DE69026851T2 (de) Verfahren zur Erhöhung von Chemilumineszenz
DE69032383T2 (de) Heterogene Bindungstests
DE69736382T2 (de) Chemilumineszente zusammensetungen und ihre verwendung zum nachweis von wasserstoffperoxid
EP0697021B1 (fr) Derives photoactivables de la biotine et leur utilisation pour la suppression des interactions dans les dosages immunologiques
DE69331570T2 (de) Agglutinationstest unter Anwendung eines multivalenten Liganden
DE69636013T2 (de) Verfahren zum erlangen von rezeptor-freigabeligand (reland)-komplexen und testansätze
DE69418501T2 (de) Immunologische Bestimmung eines Antigens oder eines Haptens
DE68921151T2 (de) Substrat-Zusammensetzung für Alkali-Phosphatase sowie ihre Verwendung bei Testverfahren.
DE69232162T2 (de) Hapten-Analoge zur Verwendung in Immunoassays
DE69007473T2 (de) Katalysierte ablagerung von markierungsmittel.
DE69016617T2 (de) Gepufferte Waschzusammensetzung, Zusammensetzung zur Unlöslichmachung, Testsätze und Verfahren zu ihrer Verwendung.
DE69323244T2 (de) Immunotests unter Verwendung von markierten Thyronin-Analogen
EP0233690B1 (fr) Conjugué d'hydantoine marquée et son utilisation dans un élément d'analyse et dans les immuno-essais
EP0992512B1 (fr) Conjugué de cortisol réduit
US5527709A (en) Immunoassays with labeled thyronine hapten analogues
DE69316112T2 (de) Immunoassays unter Verwendung von, mit Meerrettich-Peroxidase markierten Carbamazepin-Analogen
DE69232001T2 (de) Markierte Hapten-Analoge zur Verwendung in Immunoassays
EP0874994B1 (fr) Determination des groupes terminaux acide sialique de la molecule transferrine humaine
CA2062240A1 (fr) Derives d'hydantoine marques pour des dosages immunologiques
US5578457A (en) Immunoassays with novel labeled carbamazepine hapten analogues
DE69526143T2 (de) Abtrennfreier, spezifischer Bindungsassay mit Anti-Inhibitor-Antikörpern
DE69023182T2 (de) Verbindung von Stoffen zu Polymerteilchen mittels dikationischen Äthern und diese enthaltende Kits.

Legal Events

Date Code Title Description
8328 Change in the person/name/address of the agent

Representative=s name: BOEHMERT & BOEHMERT, 28209 BREMEN

8364 No opposition during term of opposition
R071 Expiry of right

Ref document number: 517327

Country of ref document: EP